Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes" [3] (multiple letters) — Nancy Richert (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes" [3] (multiple letters)
Shared by
Massimo Filippi
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes" [3] (multiple letters)
Article
2002
en
Authors
+4 more
NR
Nancy Richert
Massimo Filippi
MR
Marco Rovaris
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2001
Glatiramer acetate reduces the proportion of new MS lesions evolving into “black holes”
Massimo Filippi
,
Marco Rovaris
,
Maria A. Rocca
,
Maria Pia Sormani
,
J. S. Wolinsky
,
Gıancarlo Comı
Article
2002
Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses
Marco Rovaris
,
Maria Codella
,
Lucia Moiola
,
Angelo Ghezzi
,
Mauro Zaffaroni
,
Gianluigi Mancardi
,
Elisabetta Capello
,
Francesco Sardanelli
,
Giancarlo Comi
,
Massimo Filippi
Article
2007
Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing–remitting MS
J. A. Cohen
,
Marco Rovaris
,
Andrew Goodman
,
David Ladkani
,
Daniel Wynn
,
Massimo Filippi
Article
2000
Interferon-beta-1b reduces development of T1 black holes on MRI in secondary progressive multiple sclerosis
Frederik Barkhof
,
Jhtm van Waesberghe
,
Massimo Filippi
,
David W. Hahn
,
C. Tully
,
Tarek Yousry
,
Carlo Pozzilli
,
Alan J. Thompson
Article
2010
Phase III dose‐comparison study of glatiramer acetate for multiple sclerosis
Giancarlo Comi
,
Jeffrey A. Cohen
,
Douglas L. Arnold
,
Daniel Wynn
,
Massimo Filippi
Discussion(0)
No comments yet. Be the first to comment.